These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical characteristics and proteome modifications in two Charcot-Marie-Tooth families with the AARS1 Arg326Trp mutation. Høyer H; Busk ØL; Esbensen QY; Røsby O; Hilmarsen HT; Russell MB; Nyman TA; Braathen GJ; Nilsen HL BMC Neurol; 2022 Aug; 22(1):299. PubMed ID: 35971119 [TBL] [Abstract][Full Text] [Related]
5. Variants of aminoacyl-tRNA synthetase genes in Charcot-Marie-Tooth disease: A Korean cohort study. Nam DE; Park JH; Park CE; Jung NY; Nam SH; Kwon HM; Kim HS; Kim SB; Son WS; Choi BO; Chung KW J Peripher Nerv Syst; 2022 Mar; 27(1):38-49. PubMed ID: 34813128 [TBL] [Abstract][Full Text] [Related]
6. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Latour P; Thauvin-Robinet C; Baudelet-Méry C; Soichot P; Cusin V; Faivre L; Locatelli MC; Mayençon M; Sarcey A; Broussolle E; Camu W; David A; Rousson R Am J Hum Genet; 2010 Jan; 86(1):77-82. PubMed ID: 20045102 [TBL] [Abstract][Full Text] [Related]
7. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Zhao Z; Hashiguchi A; Hu J; Sakiyama Y; Okamoto Y; Tokunaga S; Zhu L; Shen H; Takashima H Neurology; 2012 May; 78(21):1644-9. PubMed ID: 22573628 [TBL] [Abstract][Full Text] [Related]
8. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities. Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830 [TBL] [Abstract][Full Text] [Related]
9. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS. Sun L; Wei N; Kuhle B; Blocquel D; Novick S; Matuszek Z; Zhou H; He W; Zhang J; Weber T; Horvath R; Latour P; Pan T; Schimmel P; Griffin PR; Yang XL Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753480 [TBL] [Abstract][Full Text] [Related]
10. Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview. Setlere S; Jurcenko M; Gailite L; Rots D; Kenina V Neurol Genet; 2022 Oct; 8(5):e200019. PubMed ID: 36092982 [TBL] [Abstract][Full Text] [Related]
11. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families. Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Claeys KG; Züchner S; Kennerson M; Berciano J; Garcia A; Verhoeven K; Storey E; Merory JR; Bienfait HM; Lammens M; Nelis E; Baets J; De Vriendt E; Berneman ZN; De Veuster I; Vance JM; Nicholson G; Timmerman V; De Jonghe P Brain; 2009 Jul; 132(Pt 7):1741-52. PubMed ID: 19502294 [TBL] [Abstract][Full Text] [Related]
13. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246 [TBL] [Abstract][Full Text] [Related]
14. Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients. Jung NY; Kwon HM; Nam DE; Tamanna N; Lee AJ; Kim SB; Choi BO; Chung KW Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35886002 [TBL] [Abstract][Full Text] [Related]
15. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905 [TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth disease and related inherited neuropathies. Murakami T; Garcia CA; Reiter LT; Lupski JR Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346 [TBL] [Abstract][Full Text] [Related]
17. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review. Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294 [TBL] [Abstract][Full Text] [Related]
18. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514 [TBL] [Abstract][Full Text] [Related]
19. Genotype/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland. Bansagi B; Antoniadi T; Burton-Jones S; Murphy SM; McHugh J; Alexander M; Wells R; Davies J; Hilton-Jones D; Lochmüller H; Chinnery P; Horvath R J Neurol; 2015 Aug; 262(8):1899-908. PubMed ID: 26032230 [TBL] [Abstract][Full Text] [Related]